FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure - Medtelligence

ReachMD Healthcare Image

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Optimizing AAV Outcomes: Maintenance Therapies
Optimizing AAV Outcomes: Maintenance Therapies
MinuteCE®
Optimizing AAV Outcomes: Maintenance Therapies
0.75 program credits
- Bernhard Hellmich, MD
- Silke R. Brix, MD, MRCP, SCPR
0.75 program credits
Implementing the SOC Induction Therapies in AAV 
Implementing the SOC Induction Therapies in AAV 
MinuteCE®
Implementing the SOC Induction Therapies in AAV 
0.75 program credits
- Silke R. Brix, MD, MRCP, SCPR
- Bernhard Hellmich, MD
0.75 program credits
Elevating Care for Patients With Severe Renal Disease in AAV
Elevating Care for Patients With Severe Renal Disease in AAV
MinuteCE®
Elevating Care for Patients With Severe Renal Disease in AAV
0.75 program credits
- Silke R. Brix, MD, MRCP, SCPR
- Andreas Kronbichler, MD
0.75 program credits
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Tailoring Treatment for Optimal Outcomes in Patients With AAV
MinuteCE®
Tailoring Treatment for Optimal Outcomes in Patients With AAV
0.75 program credits
- Bernhard Hellmich, MD
- Andreas Kronbichler, MD
0.75 program credits